Skip to main content

Advertisement

ADVERTISEMENT

News

News
03/02/2021
New therapies show promise of more effective therapies for kidney complications of systemic lupus erythematosus
New therapies show promise of more effective therapies for kidney complications of systemic lupus erythematosus
New therapies show promise of...
03/02/2021
Autoimmune
Q&A
02/05/2021
Ishita Aggarwal, MD, answers our questions about her research that evaluated data on quality measures for the management of lupus nephritis.
Ishita Aggarwal, MD, answers our questions about her research that evaluated data on quality measures for the management of lupus nephritis.
Ishita Aggarwal, MD, answers our...
02/05/2021
Autoimmune

Advertisement

News
02/05/2021
The authors compared baseline characteristics of persons with juvenile-onset systemic lupus erythematosus (SLE) with and without lupus nephritis to identify clinical and laboratory predictors of lupus nephritis in SLE.
The authors compared baseline characteristics of persons with juvenile-onset systemic lupus erythematosus (SLE) with and without lupus nephritis to identify clinical and laboratory predictors of lupus nephritis in SLE.
The authors compared baseline...
02/05/2021
Autoimmune
News
02/05/2021
A new therapeutic agent added to standard of care significantly improves outcomes for patients with serious complication of systemic lupus erythematosus.
A new therapeutic agent added to standard of care significantly improves outcomes for patients with serious complication of systemic lupus erythematosus.
A new therapeutic agent added to...
02/05/2021
Autoimmune
News
08/19/2020
Researchers identified several risk factors for cachexia in patients with systemic lupus erythematosus and how the syndrome can affect these patients.
Researchers identified several risk factors for cachexia in patients with systemic lupus erythematosus and how the syndrome can affect these patients.
Researchers identified several...
08/19/2020
Autoimmune

Advertisement

kidney
Conference Coverage
11/23/2011
In the interim analysis of the AURORA 2 Extension Study, the addition of voclosporin to a mycophenolate mofetil and low-dose steroid treatment routine has proved effective at reducing proteinuria.
In the interim analysis of the AURORA 2 Extension Study, the addition of voclosporin to a mycophenolate mofetil and low-dose steroid treatment routine has proved effective at reducing proteinuria.
In the interim analysis of the...
11/23/2011
Autoimmune
News
09/07/2011
A study of Medicaid claims found that patients with systemic lupus erythematosus often need care for vaccine-preventable illnesses.
A study of Medicaid claims found that patients with systemic lupus erythematosus often need care for vaccine-preventable illnesses.
A study of Medicaid claims found...
09/07/2011
Rheumatology & Arthritis

Advertisement